InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Thursday, 03/19/2015 7:00:57 AM

Thursday, March 19, 2015 7:00:57 AM

Post# of 403158
What's next for K? Phase 1 wrapping up. Next clear step appears to be the Bologna trial, as a combo with cytarabine. What else?

Aprea chose ovarian CA with Cisplatinum and Doxorubicin as an add on for salvage chemo for PiSSARO and their p53 drug.

What else on the slate for Kevetrin? Unsure if there has ever been an indication.

I do not know enough about cancer trials to know if each time you use a drug, say, K, with a new combo, that you must calculate dosing over again. So it appears to be again in Pissaro where first part of trial for APR-246 is to establish dosing, so it is a Phase 1-2 together.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News